|
|
|
Volumn 20, Issue 9, 2007, Pages 56-67
|
|
Biopharmaceuticals: Approval trends in 2006
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ELAPRASE;
GALSULFASE;
GLUCAN 1,4 ALPHA GLUCOSIDASE;
HUMAN GROWTH HORMONE;
IDURONATE 2 SULFATASE;
INSULIN;
INSULIN LISPRO;
NATALIZUMAB;
PANITUMUMAB;
PARATHYROID HORMONE;
PEGAPTANIB;
PREOTACT;
RANIBIZUMAB;
RECOMBINANT ANTITHROMBIN III;
RECOMBINANT GLUCAN 1,4 ALPHA GLUCOSIDASE;
SILGARD;
UNCLASSIFIED DRUG;
VALTROPIN;
VECTIBIX;
WART VIRUS VACCINE;
ANAPHYLAXIS;
ANTITHROMBIN DEFICIENCY;
BLEEDING;
CLINICAL FEATURE;
CLINICAL TRIAL;
COLORECTAL CANCER;
CONDYLOMA;
CONJUNCTIVAL HEMORRHAGE;
DIABETES MELLITUS;
DIZZINESS;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG HALF LIFE;
DRUG MANUFACTURE;
DRUG MARKETING;
DRUG MECHANISM;
DRUG SAFETY;
EDEMA;
EYE INFLAMMATION;
EYE PAIN;
FATIGUE;
FEVER;
FOOD AND DRUG ADMINISTRATION;
GLYCOGEN STORAGE DISEASE TYPE 2;
GROWTH DISORDER;
HEADACHE;
HUMAN;
HUNTER SYNDROME;
HYPERCALCEMIA;
HYPERCALCIURIA;
HYPERSENSITIVITY REACTION;
INFECTION;
INJECTION SITE REACTION;
INTRAOCULAR PRESSURE;
MONOTHERAPY;
MORQUIO SYNDROME;
MULTIPLE SCLEROSIS;
NAUSEA;
OSTEOPOROSIS;
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY;
RASH;
RETINA MACULA AGE RELATED DEGENERATION;
REVIEW;
SIDE EFFECT;
SKIN MANIFESTATION;
SKIN TOXICITY;
UTERINE CERVIX CANCER;
VAGINA CANCER;
VITREOUS FLOATERS;
|
|
EID: 35348843937
PISSN: 1542166X
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (9)
|
|
References (5)
|
